NCT04936334View on ClinicalTrials.gov

The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 11, 2021

Primary Completion Date

July 18, 2022

Study Completion Date

July 19, 2022

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

68Ga-PSMA-11 PET Scan

Patients will undergo injection of 68Ga-PSMA-11 at the time of their pre treatment PSMA PET scan and followed until 12 months post surgery.

Trial Locations (1)

46202

Indiana University Health University Hospital, Indianapolis

All Listed Sponsors
lead

Clinton Bahler

OTHER